Jamjoom Pharma launches new product, Veratol

Pharmaceutical company Jamjoom Pharma recently inaugurated its new product, Veratol, in Jeddah and Riyadh. It is the first of its kind in Saudi Arabia and the Middle East.

The event was held in the presence of specialists in the pharmaceutical industry, headed by Professor Sameer Zimmo, Professor Paul Clayton, media professionals and a group of doctors, pharmacists and those interested in therapeutic nutrition.

Professor Clayton, senior scientific adviser to the British government’s committee on drug safety, and known for his academic work as a lecturer at the Institute of Food, Brain and Behavior at the University of Oxford, gave a scientific lecture on Resveratrol, one of the most important ingredients of the new product, Veratol, and the most recently researched molecule in the field of dietary supplements.

“The new product comes within the framework of the plans of Jamjoom Pharma for the future expansion of health and beauty, and skin care products, which contribute to the safe treatment of the skin and protect it from diseases and sideeffects that are associated with some other products that include fatty or chemical substances,” the company said.

Yousuf Jamjoom, sales development manager at Jamjoom Pharma, said that the launch of Veratol in the market is part of the company’s continuous contribution to enrich the Saudi and Gulf markets with high-quality, safe, effective and competitively priced products that meet the needs and expectations of consumers.

“Jamjoom Pharma has demonstrated its pioneering and well-established position as a leading pharmaceutical manufacturer,” he added.